More on atorvastatin and fibrinogen

被引:6
作者
Otto, C [1 ]
Schwandt, P [1 ]
机构
[1] Univ Munich, Klinikum Grosshadern, Dept Med 2, D-81377 Munich, Germany
关键词
D O I
10.1016/S0021-9150(00)00472-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:591 / 592
页数:2
相关论文
共 11 条
[1]   Effect of atorvastatin versus simvastatin on lipid profile and plasma fibrinogen in patients with hypercholesterolaemia - A pilot, randomised, double-blind, dose-titrating study [J].
Athyros, VG ;
Papageorgiou, AA ;
Hatzikonstandinou, HA ;
Athyrou, VV ;
Kontopoulos, AG .
CLINICAL DRUG INVESTIGATION, 1998, 16 (03) :219-227
[2]   Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia [J].
BakkerArkema, RG ;
Davidson, MH ;
Goldstein, RJ ;
Davignon, J ;
Isaacsohn, JL ;
Weiss, SR ;
Keilson, LM ;
Brown, WV ;
Miller, VT ;
Shurzinske, LJ ;
Black, DM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (02) :128-133
[3]  
Bertolotto A, 1999, ATHEROSCLEROSIS, V143, P455
[4]   Comparison of one-year efficacy and safety of Atorvastatin versus Lovastatin in primary hypercholesterolemia [J].
Davidson, M ;
McKenney, J ;
Stein, E ;
Schrott, H ;
BakkerArkema, R ;
Fayyad, R ;
Black, D .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (11) :1475-1481
[5]   Comparative dose efficacy study of Atorvastatin versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in patients with hypercholesterolemia (The CURVES study) [J].
Jones, P ;
Kafonek, S ;
Laurora, I ;
Hunninghake, D .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (05) :582-587
[6]   Atorvastatin: An effective lipid-modifying agent in familial hypercholesterolemia [J].
Marais, AD ;
Firth, JC ;
Bateman, ME ;
Byrnes, P ;
Martens, C ;
Mountney, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (08) :1527-1531
[7]  
Nair DR, 1998, LANCET, V351, P1430, DOI 10.1016/S0140-6736(98)26019-3
[8]  
OTTO C, IN PRESS THER APHERE, P2151
[9]   Effect of atorvastatin on plasma fibrinogen [J].
Wierzbicki, AS ;
Lumb, PJ ;
Semra, YK ;
Crook, MA .
LANCET, 1998, 351 (9102) :569-570
[10]  
Wierzbicki AS, 2000, ATHEROSCLEROSIS, V148, P204